未登录.png)
分享.png)
收藏分享 收藏 分享 收藏 分享 收藏 分享 收藏 Safety, immunogenicity and immune persistence of a lyophilized purified human diploid cells rabies vaccine following rabies PEP regimen Essen and Zagreb: A randomized, blinded controlled phase 3 trial in healthy participants aged 10-60 years old冻干纯化人二倍体细胞狂犬病疫苗在 Essen 和 Zagreb 狂犬病 PEP 方案后的安全性、免疫原性和免疫持久性：一项在 10-60 岁健康受试者中进行的随机、盲法对照的 III 期试验
Li, Guifan; Cao, Shouchun; Xu, Bidan; Hu, Jialei; Zhang, Lei; Shi, Leitai; Zhao, Danhua; Li, Yixin; Liu, Yafei; Liang, Qi; Wu, Xiaohong 分享 收藏 分享 收藏 Fumonisins in maize and its products from Dalian region, China, and risk assessment by deterministic and probabilistic approaches大连地区玉米及其制品中的伏马毒素及其通过确定性方法和概率性方法的风险评估Song, Xiaoyun; Song, Yue; Gu, Junjie; Zhang, Mei; Zhang, Lei; Zheng, Xiaonan; Guo, Lin; Liu, Xiaoting 分享 收藏 分享 收藏 Deciphering the functional importance of comammox vs. canonical ammonia oxidisers in nitrification and N2O emissions in acidic agricultural soilsTan, Che; Yin, Chang; Zhang, Lei; Zeng, Yu; Gubry-Rangin, Cecile; Chen, Hao; Gao, Zixiang; Peng, Hongyun; Li, Tingqiang; Liang, Yongchao 分享 收藏 分享 收藏 分享 收藏 分享 收藏 分享 收藏 PANoptosis: bridging apoptosis, pyroptosis, and necroptosis in cancer progression and treatmentGao, Jie; Xiong, Anying; Liu, Jiliu; Li, Xiaolan; Wang, Junyi; Zhang, Lei; Liu, Yao; Xiong, Ying; Li, Guoping; He, Xiang 分享 收藏 Lymphocyte and neutrophil count combined with intestinal bacteria abundance predict the severity of COVID-19Chen, Liuying; Yin, Zhongwei; Zhou, Dan; Li, Xin; Yu, Cheng; Luo, Chang; Jin, Yu; Zhang, Lei; Song, Jun; Rasche, Leo; Einsele, Hermann; Tu, Lei; Zhou, Xiang; Bai, Tao; Hou, Xiaohua 分享 收藏 Ultrasensitive and Quantitative DNA Methylation Detection Method Based on the MutS ProteinZhang, Lei; Zhang, Wei; Mu, Yaoqin; Hu, Hao; Dong, Kejun; Wen, Xu; Ye, Zhengxin; Sun, Qiangqiang; Yan, Bei; Mao, Zenghui; Xiao, Xianjin 分享 收藏 The Eph/ephrin system symphony of gut inflammationQiu, Peishan; Li, Daojiang; Xiao, Cong; Xu, Fei; Chen, Xiaoyu; Chang, Ying; Liu, Lan; Zhang, Lei; Zhao, Qiu; Chen, Yuhua 分享 收藏 The preliminary data from a single-arm, open- label, multicenter phase II clinical trial: KN046 combined with axitinib as first-line (1L) treatment for NSCLCZhao, Y.; Huang, Y.; Fang, W.; Yang, Y.; Shi, J.; Zhao, H.; Meng, X.; Zhang, L.; Liu, A.; Xu, T.; Liu, Y.; Wang, N.; Zhang, L. 分享 收藏 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png)
VACCINE.png)
